HIV infection and AIDS
European Testing Week 2020
The European Testing Week is a European campaign that encourages partner organisations in Europe to unite for one week twice a year to increase testing efforts and promote awareness on the benefits of earlier hepatitis and HIV testing.Read more
Data, trends, analyses: HIV and AIDS data for Europe
Know the epidemic: get the 2018 data from the 53 countries of the WHO European Region.
Responding to HIV: how is Europe doing?
Monitoring the Dublin Declaration Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central AsiaCheck the progress reports
Guidance on HIV, hepatitis B and C testing
Tackling the undiagnosed fraction: the ECDC Guidance outlines whom, where, how and when to test for viral hepatitis and HIV and offers options for testing strategies that are applicable to all healthcare settings and beyond, e.g. self-sampling and self-testing.Read the Guidance
Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction
HIV and migrants: Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia (2018 progress report)
HIV and men who have sex with men - Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area
Threats and outbreaks
Current and past threats and outbreaks of HIV infection and AIDS. Risk assessments.
Public health guidance on HIV and STI prevention among men who have sex with men
17 Jun 2015 - This guidance, based on a systematic review of the literature and expert opinion, suggests that there is good evidence to ensure that some key components are considered for inclusion in national and sub-national public health programmes in countries in Europe.
The benefits of HIV treatment: undetectable means you do not pass on the virus
25 Jul 2018 - Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
Effective use of digital platforms for STI/HIV prevention among MSM in the EU/EEA
This ECDC series provides comprehensive guides to the effective use of digital platforms for STI/HIV prevention among MSM in the EU/EEA. The guides incorporate the expertise of stakeholders, scientific literature relating to social media and digital platforms, commercial sector best practice and engagement with the platform companies themselves.Read more
Infographic: HIV and AIDS in Europe 2017
Europe experiences a persistent HIV epidemic, with only little changes in notifications during the last decade in the EU/EEA. One reason for this: an estimated 120 000 Europeans are living with undiagnosed HIV in the EU/EEA, which means that about 1 in 7 of those living with HIV are not aware of their status. And it takes on average three years from HIV infection to diagnosis.Read more
Disease programmes and networks
HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance